Potent Compound & Containment Experts
"Isolators increasingly make sense in biotech filling and finishing suites because the value of biologics per unit weight or volume is so high. Before blockbuster biological became commonplace, it was simply easier to process these products in classified rooms rather than invest in dedicated isolator technology. Today, you just can't afford to lose a batch."
Sterling Kline, RA, IPS, Director of Project Development
"Cleanroom Alternatives", Genetic Engineering News, Volume 26,
NO: 21, December 2006
Sterling Kline, RA
Sterile Manufacturing Production Facilities, Clinical Manufacturing, Pilot Plants, Potent Compounds/Cytotoxic Products, Isolation Technology
John Gilroy, PE
Design Engineering, Project Management, Systems Analysis, Cost Estimating, Energy Assessment, Specializing in OSD, Sterile, Aseptic, Potent and Cytotoxic
Gerry Cerulli
Bulk/API Plant Design, Containment and CIP Technology, Biotech Plant Design
Andy Haines, PE
Mechanical Design of Pharmaceutical R&D Laboratories, All OSD Forms, Sterile and Clinical Manufacturing Production and Biotech Facilities using High Potency Compounds
George Petroka, CIH, CSP, RBP
Potent Compounds, SOP for Potent Compounds in R&D, API, and Pharmaceutical Finishing Facilities, Design/Construction of Potent Compound, Cytotoxic Facilities
Richard Lesnik
Operations Analysis, Pharma Manufacturing, Potent Compounds, Economic Analysis, Biotech Processing